Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention

European Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2013, Pages 703-709

  Garcia, Beate Hennie ^a   Småbrekke, Lars ^b   Trovik, Thor ^c   Giverhaug, Trude ^c  

^a Hospital Pharmacy of North Norway Trust   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Adherence; Clinical practice guidelines (CPGs); Coronary heart disease (CHD); Medication assessment tool (MAT)

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOCUMENTATION; ECHOCARDIOGRAPHY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION ASSESSMENT TOOL FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE; MEDICATION COMPLIANCE; PATIENT CARE; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SMOKING CESSATION; STENT; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; CORONARY ARTERY DISEASE; EQUIPMENT; HEALTH CARE QUALITY; METHODOLOGY; MIDDLE AGED; PRESCRIPTION; RECURRENT DISEASE; RISK REDUCTION; STANDARD; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CORONARY DISEASE; DRUG PRESCRIPTIONS; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUALITY INDICATORS, HEALTH CARE; RECURRENCE; RETROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; STENTS; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877133363     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1402-7     Document Type: Article

References (29)

1. European Society of Cardiology. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.escardio.org/Pages/index.aspx
2. American Heart Association. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.heart.org/HEARTORG/
3. National Institute of Health and Clinical Excellence. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.nice.org.uk/
4. Scottish Intercollegate Guideline Network. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.sign.ac.uk/
5. American College of Cardiology. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.cardiosource.org/
6. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U (2009) EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16(2):121-137
7. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA (2004) Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 109:745-749
8. Gouya G, Reichardt B, Ohrenberger G, Wolzt M (2007) Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol 22(3):145-149
9. Jackevicius CA, Li P, Tu JV (2008) Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 117(8):1028-1036
10. Kuepper-Nybelen J, Hellmich M, Abbas S, Ihle P, Griebenow R, Schubert I (2012) Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data. Eur J Clin Pharmacol. Apr 4
11. Campbell SM, Roland MO, Shekelle PG, Cantrill JA, Buetow SA, Cragg DK (1999) Development of review criteria for assessing the quality of management of stable angina, adult asthma, and noninsulin dependent diabetes mellitus in general practice. Qual Health Care 8(1):6-15
12. McAnaw JJ, Hudson S, McGlynn S (2003) Development of an evidence-based medication assessment tool to demonstrate the quality of drug therapy use in patients with heart failure. Int J Pharm Pract 11(suppl):R17
13. Ernst A, Kinnear M, Hudson S (2005) Quality of prescribing: a study of guideline adherence of medication in patients with diabetes mellitus. Pract Diabetes Int 22(8):285-290
14. Kamyar M, Johnson BJ, McAnaw JJ, Lemmens-Gruber R, Hudson SA (2008) Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus. Pharm World Sci 30(1):120-127
15. Hakonsen GD, Hudson S, Loennechen T (2006) Design and validation of a medication assessment tool for cancer pain management. Pharm World Sci 28(6):342-351
16. Hakonsen GD, Strelec P, Campbell D, Hudson S, Loennechen T (2009) Adherence to medication guideline criteria in cancer pain management. J Pain Symptom Manag 37(6):1006-1018
17. SP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease. Pharmacoepidemiol Drug Saf 20(3):249-257
18. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(Suppl 2):S1-S113
19. Task FM, Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A et al (2005) Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J 26(8):804-847
20. Task FM, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A et al (2007) Guidelines for the diagnosis and treatment of nonST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of nonST-Segment elevation acute coronary syndromes of the european society of cardiology. Eur Heart J 28(13):1598-1660
21. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology, Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24(1):28-66
22. Beregnet folkemengde 31. desember 2009 [Estimated population pr. 31 December 2009]. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.unn.no/getfile.php/UNN-Internett/Enhet/Samhandling-telemed/ folkemengde.pdf
23. Kommuner og befolkning pr. helseforetak [Communities and inhabitants for each Health Trust]. Internet home page 2010 [cited 2010 Jul 13]; Available from: URL: http://www.helse-nord.no/befolkning-pr-helseforetak/category22368.html
24. Robson C (2002) Real world research. A resource for social scientists and practiotioner-reserachers, 2nd edn. Blackwell Publishing, Malden
25. Chinwong S, Reid F, McGlynn S, Hudson S, Flapan A (2004) The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients. Pharm World Sci 26(2):96-101
26. Kotseva K (2009) Treatment of patients with coronary heart disease fails to meet standards of european guidelines: results of EUROASPIRE surveys. Rev Esp Cardiol 62(10):1095-1098
27. Zullo MD, Jackson LW, Whalen CC, Dolansky MA (2012) Evaluation of the recommended core components of cardiac rehabilitation practice: an opportunity for quality improvement. J Cardiopulm Rehabil Prev 32(1):32-40
28. Death rates in Norway. Statistisk sentralbyrå (Eng: Statistics Norway) 2012 [cited 2012 May 3]
29. Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K et al (2010) Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart 96(21):1744-1749